Deals in Depth: June/July 2011
For up to $775 million in pre-commercial payments, Alios licensed Vertex its preclinical hepatitis C nucleotide analogues. PBMs Express Scripts and Medco decided to merge in a $27.6 billion deal. Two private equity take-outs of wound care device company Kinetic Concepts and automated reagents systems producer Immucor resulted in billion-dollar acquisitions. In June and July, biopharma companies raised a total of $2 billion, while device firms amassed $876 million.
You may also be interested in...
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Drug companies have their last chance to negotiate which documents and information Italy’s regulator, AIFA, will be entitled to request of them when they submit pricing and reimbursement applications.
Sandoz sees key opportunities ahead in both the US and Canadian biosimilars markets, the firm’s US vice-president for marketing, market access and patient services, Sheila Frame, tells Generics Bulletin in the second part of an exclusive interview.